Bonny Parkinson : Citation Profile


Are you Bonny Parkinson?

Macquarie University

2

H index

1

i10 index

27

Citations

RESEARCH PRODUCTION:

13

Articles

2

Papers

RESEARCH ACTIVITY:

   11 years (2011 - 2022). See details.
   Cites by year: 2
   Journals where Bonny Parkinson has often published
   Relations with other researchers
   Recent citing documents: 0.    Total self citations: 1 (3.57 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/ppa1146
   Updated: 2024-12-03    RAS profile: 2022-09-01    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Bonny Parkinson.

Is cited by:

Lancsar, Emily (3)

Petrie, Dennis (2)

Gyrd-Hansen, Dorte (1)

Vass, Caroline (1)

EPSTEIN, DAVID (1)

Chen, Gang (1)

Gu, Yuanyuan (1)

Brazier, John (1)

van Exel, Job (1)

Haywood, Philip (1)

Cites to:

Hall, Jane (3)

Husereau, Don (2)

Savage, Elizabeth (2)

Jones, Andrew (2)

Lancsar, Emily (2)

Viney, Rosalie (2)

Swait, Joffre (2)

Sermet, Catherine (2)

Keane, Michael (1)

Wasi, Nada (1)

Moreno-Ternero, Juan (1)

Main data


Where Bonny Parkinson has published?


Journals with more than one article published# docs
PharmacoEconomics5
Applied Health Economics and Health Policy4
The European Journal of Health Economics2

Working Papers Series with more than one paper published# docs
Working Papers / CHERE, University of Technology, Sydney2

Recent works citing Bonny Parkinson (2024 and 2023)


YearTitle of citing document

Works by Bonny Parkinson:


YearTitleTypeCited
2011Considering consumer choice in the economic evaluation of mandatory health programmes: A review In: Health Policy.
[Full Text][Citation analysis]
article1
2012Measuring the loss of consumer choice in mandatory health programs using Discrete Choice Experiments. CHERE Working Paper 2012/04 In: Working Papers.
[Citation analysis]
paper0
2013Pharmaceutical policy in Australia. CHERE Working Paper 2013/01 In: Working Papers.
[Full Text][Citation analysis]
paper0
2011Integrating Health Economics Into the Product Development Cycle In: Medical Decision Making.
[Full Text][Citation analysis]
article5
2013Measuring the Loss of Consumer Choice in Mandatory Health Programmes Using Discrete Choice Experiments In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article2
2018The Real-World Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Stenting in High-Risk Patients: Propensity Score-Matched Analysis of a Single-Centre Experience In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2019Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2019Correction to: Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2014Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2022The cost-effectiveness of unilateral cochlear implants in UK adults In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2015Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review In: PharmacoEconomics.
[Full Text][Citation analysis]
article15
2016Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2016Authors’ Reply to Palozzo and Messori: ‘‘Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review’’ In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2019Is Reclassification of the Oral Contraceptive Pill from Prescription to Pharmacist-Only Cost Effective? Application of an Economic Evaluation Approach to Regulatory Decisions In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2022Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia In: PharmacoEconomics.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team